Cargando…

Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents

Despite the substantial clinical success of aspirin and clopidogrel in secondary prevention of ischemic stroke, up to 40% of patients remain resistant to the available antiplatelet treatment. Therefore, there is an urgent clinical need to develop novel antiplatelet agents with a novel mechanism of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcinkowska, Monika, Kotańska, Magdalena, Zagórska, Agnieszka, Śniecikowska, Joanna, Kubacka, Monika, Siwek, Agata, Bucki, Adam, Pawłowski, Maciej, Bednarski, Marek, Sapa, Jacek, Starek, Małgorzata, Dąbrowska, Monika, Kołaczkowski, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010133/ https://www.ncbi.nlm.nih.gov/pubmed/29482394 http://dx.doi.org/10.1080/14756366.2018.1437155

Ejemplares similares

Idalopirdine, a selective 5-HT(6) receptor antagonist, reduces food intake and body weight in a model of excessive eating
por: Kotańska, Magdalena, et al.
Publicado: (2018)

Novel serotonin 5-HT(2A) receptor antagonists derived from 4-phenylcyclohexane-5-spiro-and 5-methyl-5-phenyl-hydantoin, for use as potential antiplatelet agents
por: Czopek, Anna, et al.
Publicado: (2021)

Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α(2)-adrenoceptor and trace amine-associated receptor 1 ligand
por: Kotańska, Magdalena, et al.
Publicado: (2023)

Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT(1A) receptor partial agonists
por: Partyka, Anna, et al.
Publicado: (2020)

Serotonin transporter activity of imidazolidine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives in aspect of their acid–base properties
por: Zagórska, Agnieszka, et al.
Publicado: (2011)

Dual Molecules Targeting 5-HT(6) and GABA-A Receptors as a New Approach to Combat Depression Associated with Neuroinflammation
por: Marcinkowska, Monika, et al.
Publicado: (2023)

Novel Arylpiperazine Derivatives of Salicylamide with α(1)-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats
por: Żmudzka, Elżbieta, et al.
Publicado: (2022)

Multifunctional Arylsulfone and Arylsulfonamide-Based Ligands with Prominent Mood-Modulating Activity and Benign Safety Profile, Targeting Neuropsychiatric Symptoms of Dementia
por: Marcinkowska, Monika, et al.
Publicado: (2021)

Impact of N-Alkylamino Substituents on Serotonin Receptor (5-HTR) Affinity and Phosphodiesterase 10A (PDE10A) Inhibition of Isoindole-1,3-dione Derivatives
por: Czopek, Anna, et al.
Publicado: (2020)

Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist
por: Kotańska, Magdalena, et al.
Publicado: (2017)

Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome
por: Kubacka, Monika, et al.
Publicado: (2023)

2-(4-Fluorophenyl)-1H-benzo[d]imidazole as a Promising Template for the Development of Metabolically Robust, α1β2γ2GABA-A Receptor-Positive Allosteric Modulators
por: Marcinkowska, Monika, et al.
Publicado: (2023)

Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates
por: Marcinkowska, Monika, et al.
Publicado: (2020)

Bioresearch of New 1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones
por: Szkatuła, Dominika, et al.
Publicado: (2020)

KSK-74: Dual Histamine H(3) and Sigma-2 Receptor Ligand with Anti-Obesity Potential
por: Mika, Kamil, et al.
Publicado: (2022)

MH-76, a Novel Non-Quinazoline α(1)-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats
por: Kubacka, Monika, et al.
Publicado: (2021)

Idalopirdine – a small molecule antagonist of 5-HT(6) with therapeutic potential against obesity
por: Dudek, Magdalena, et al.
Publicado: (2015)

Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones
por: Bielenica, Anna, et al.
Publicado: (2011)

Biologically Active 1-Arylpiperazines. Synthesis of New N-(4-Aryl-1-piperazinyl)alkyl Derivatives of Quinazolidin-4(3H)-one, 2,3-Dihydrophthalazine-1,4-dione and 1,2-Dihydropyridazine-3,6-dione as Potential Serotonin Receptor Ligands
por: Kowalski, Piotr, et al.
Publicado: (2001)

Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating
por: Kotańska, Magdalena, et al.
Publicado: (2021)

Quinazoline-2,4(1H,3H)-dione
por: Liu, Ge
Publicado: (2008)

1,4-Dihydroxyquinoxaline-2,3(1H,4H)-dione
por: Abu-El-Halawah, Rajab, et al.
Publicado: (2008)

Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT(6) Receptor Partial Agonist and Dopamine Transporter Inhibitor
por: Kotańska, Magdalena, et al.
Publicado: (2017)

1-Methyl-4H-3,1-benzoxazine-2,4(1H)dione
por: Deifel, Nicholas P., et al.
Publicado: (2010)

Enantioselective amination of 4-alkylisoquinoline-1,3(2H,4H)-dione derivatives
por: Cheng, Cheng, et al.
Publicado: (2020)

Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT(1A) Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile
por: Sniecikowska, Joanna, et al.
Publicado: (2020)

Design and synthesis of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-2H-1,2,3-triazole derivatives as colchicine binding site inhibitors
por: Wu, Yue, et al.
Publicado: (2017)

The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects
por: Kotańska, Magdalena, et al.
Publicado: (2021)

Evaluation of Some Safety Parameters of Dual Histamine H(3) and Sigma-2 Receptor Ligands with Anti-Obesity Potential
por: Mika, Kamil, et al.
Publicado: (2023)

Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers
por: Wang, Chao, et al.
Publicado: (2021)

1H-Benzo[g]pteridine-2,4-dione
por: Uppu, Rao M., et al.
Publicado: (2023)

1-(4-tert-Butylbenzyl)pyrimidine-2,4(1H,3H)-dione
por: Wang, Hong-Sheng, et al.
Publicado: (2012)

6-Chloro-8-methyl-4H-3,1-benzoxazine-2,4(1H)-dione
por: Zhou, Yan-Ling, et al.
Publicado: (2010)

1,1′-Bis(4-fluorophenyl)-3,3′-diisobutyl-4,4′-diphenoxy-1H,1′H-4,4′-bipyrazole-5,5′(4H,4′H)-dione
por: Fun, Hoong-Kun, et al.
Publicado: (2011)

3-Benzyl-4-ethyl-1H-1,2,4-triazole-5(4H)-thione
por: Karczmarzyk, Zbigniew, et al.
Publicado: (2013)

Synthesis and Determination of Physicochemical Properties of New 3-(4-Arylpiperazin-1-yl)-2-hydroxypropyl 4-Alkoxyethoxybenzoates
por: Marvanova, Pavlina, et al.
Publicado: (2016)

Synthesis and Characterization of New 3-(4-Arylpiperazin-1-yl)-2-hydroxypropyl 4-Propoxybenzoates and Their Hydrochloride Salts
por: Marvanova, Pavlina, et al.
Publicado: (2016)

3,8-Dimethylquinazoline-2,4(1H,3H)-dione
por: Qin, Wei-Yan, et al.
Publicado: (2011)

Modulation of the MOP Receptor (μ Opioid Receptor) by Imidazo[1,2-a]imidazole-5,6-Diones: In Search of the Elucidation of the Mechanism of Action
por: Straszak, Dominik, et al.
Publicado: (2022)

1,3-Bis(4-methylbenzyl)pyrimidine-2,4(1H,3H)-dione
por: Li, Gong-Chun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_b49281thlmaubqftcketnjfang